These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32099386)

  • 1. miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer.
    Cai Z; Zhang F; Chen W; Zhang J; Li H
    Onco Targets Ther; 2019; 12():11805-11816. PubMed ID: 32099386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
    Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
    Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
    J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MicroRNAs in Treatment Response in Prostate Cancer.
    Razdan A; de Souza P; Roberts TL
    Curr Cancer Drug Targets; 2018; 18(10):929-944. PubMed ID: 29644941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Liu X; Liu X; Wu Y; Fang Z; Wu Q; Wu C; Hao Y; Yang X; Zhao J; Li J; Wang Q; Yang Z; Xu J; Hu X; Tan M; Li L
    Cell Physiol Biochem; 2018; 48(1):87-98. PubMed ID: 30001529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.
    He SJ; Xiang CQ; Zhang Y; Lu XT; Chen HW; Xiong LX
    Onco Targets Ther; 2017; 10():3435-3451. PubMed ID: 28744148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer.
    Goodspeed A; Jean A; Costello JC
    Eur Urol; 2019 Feb; 75(2):242-250. PubMed ID: 30414698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer.
    Alharbi M; Zuñiga F; Elfeky O; Guanzon D; Lai A; Rice GE; Perrin L; Hooper J; Salomon C
    Endocr Relat Cancer; 2018 Dec; 25(12):R663-R685. PubMed ID: 30400025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
    Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
    Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-mediated EMT and CSCs in cancer chemoresistance.
    Dong B; Li S; Zhu S; Yi M; Luo S; Wu K
    Exp Hematol Oncol; 2021 Feb; 10(1):12. PubMed ID: 33579377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors.
    Mu Q; Lv Y; Luo C; Liu X; Huang C; Xiu Y; Tang L
    Front Pharmacol; 2021; 12():709324. PubMed ID: 34566636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNAs in bladder cancer.
    Enokida H; Yoshino H; Matsushita R; Nakagawa M
    Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer.
    Falzone L; Candido S; Salemi R; Basile MS; Scalisi A; McCubrey JA; Torino F; Signorelli SS; Montella M; Libra M
    Oncotarget; 2016 Nov; 7(45):72758-72766. PubMed ID: 27602581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.